[1] SHIBOSKI C H,SHIBOSKI S C,SEROR R,et al.2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome:a consensus and data-driven methodology involving three international patient cohorts[J].Arthritis Rheumatol,2017,69(1):35-45.
[2] THORNE I,SUTCLIFFE N.Sjögren's syndrome[J].Br J Hosp Med,2017,78(8):438-442.
[3] 王月,丁长伟.干燥综合征之涎腺的影像学检查研究进展[J].现代医学,2021,49(5):586-591.
[4] CIFUENTES M,DEL BARRIO-DÍAZ P,VERA-KELLET C.Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome:a double-blind randomized controlled trial[J].Br J Dermatol,2018,179(5):1056-1061.
[5] GOTTENBERG J E,RAVAUD P,PUÉCHAL X,et al.Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome:the JOQUER randomized clinical trial[J].JAMA,2014,312(3):249-258.
[6] NEGRINI S,EMMI G,GRECO M,et al.Sjögren's syndrome:a systemic autoimmune disease[J].Clin Exp Med,2022,22(1):9-25.
[7] RAMOS-CASALS M,BRITO-ZERÓN P,SOLANS R,et al.Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index:analysis of 921 Spanish patients(GEAS-SS Registry)[J].Rheumatol(Oxford),2014,53(2):321-331.
[8] 李飞燕,向云霞,谢华灵,等.干燥综合征患者焦虑和抑郁状况及影响因素概述[J].当代医学,2021,27(31):188-191.
[9] SCIFO E,PABBA M,KAPADIA F,et al.Sustained molecular pathology across episodes and remission in major depressive disorder[J].Biol Psychiatry,2018,83(1):81-89.
[10] BELMAKER R H,AGAM G.Major depressive disorder[J].New Engl J Med,2008,358(1):55-68.
[11] 涂青云,韩翱瀚,覃玉,等.江苏省成年居民抑郁症患病情况及其影响因素分析[J].现代医学,2018,46(11):1205-1209.
[12] HUANG Y,WANG Y,WANG H,et al.Prevalence of mental disorders in China:a cross-sectional epidemiological study[J].Lancet Psychiatry,2019,6(3):211-224.
[13] MOUSSAVI S,CHATTERJI S,VERDES E,et al.Depression,chronic diseases,and decrements in health:results from the World Health Surveys[J].Lancet,2007,370(9590):851-858.
[14] CUI Y,XIA L,LI L,et al.Anxiety and depression in primary Sjögren's syndrome:a cross-sectional study[J].BMC Psychiatry,2018,18(1):131.
[15] CUI Y,LI L,YIN R,et al.Depression in primary Sjögren's syndrome:a systematic review and meta-analysis[J].Psychol Health Med,2018,23(2):198-209.
[16] MILIN M,CORNEC D,CHASTAING M,et al.Sicca symptoms are associated with similar fatigue,anxiety,depression,and quality-of-life impairments in patients with and without primary sjögren's syndrome[J].Joint Bone Spine,2016,83(6):681-685.
[17] DAVIES N M,HOLMES M V,DAVEY S G.Reading mendelian randomisation studies:a guide,glossary,and checklist for clinicians[J].BMJ,2018,362:k601.
[18] LAWLOR D A,HARBORD R M,STERNE J A,et al.Mendelian randomization:using genes as instruments for making causal inferences in epidemiology[J].Stat Med,2008,27(8):1133-1163.
[19] EMDIN C A,KHERA A V,KATHIRESAN S.Mendelian randomization[J].JAMA,2017,318(19):1925-1926.
[20] REES J M B,WOOD A M,BURGESS S.Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy[J].Stat Med,2017,36(29):4705-4718.
[21] HOWARD D M,ADAMS M J,SHIRALI M,et al.Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways[J].Nat Commun,2018,9(1):1470.
[22] BOWDEN J,DAVEY S G,BURGESS S.Mendelian randomization with invalid instruments:effect estimation and bias detection through Egger regression[J].Int J Epidemiol,2015,44(2):512-525.
[23] STAIGER D,STOCK J H.Instrumental variables regression with weak instruments[J].Econometrica,1997,65(3):557-586.
[24] BOWDEN J,HEMANI G,DAVEY S G.Invited commentary:detecting individual and global horizontal pleiotropy in mendelian randomization-a job for the humble heterogeneity statistic?[J].Am J Epidemiol,2018,187(12):2681-2685.
[25] XIE B,CHEN Y,ZHANG S,et al.The expression of P2X7 receptors on peripheral blood mononuclear cells in patients with primary Sjögren's syndrome and its correlation with anxiety and depression[J].Clin Exp Rheumatol,2014,32(3):354-360. |
